Among others, ALL-related targets of miR-181a and miR-181b include ERK/MAPK, mTOR and NF-κB signaling pathways, whereas the expression of this cluster seems to be abundant in the early B-cell stage and to decline progressively with maturation [198]. This evidence concerns the gene MAPK1 and acute lymphoblastic leukemia.